ストックスクリーナーアプリを入手
2.755
3.80%
0.105
前日終値:
$2.65
開ける：
$2.84
24時間の取引高:
352.99K
Relative Volume:
0.27
時価総額：
$181.84M
収益：
$69.23M
当期純損益:
$-33.10M
株価収益率:
-2.3347
EPS:
-1.18
ネットキャッシュフロー:
$-39.26M
1週間 パフォーマンス:
-10.98%
1か月 パフォーマンス:
-3.48%
6か月 パフォーマンス:
-39.94%
1年 パフォーマンス:
+167.06%
1日の値動き範囲:
$2.70
$2.87
1週間の範囲:
$2.61
$3.135
52週間の値動き範囲:
$0.52
$5.92
Neuronetics Inc Stock (STIM) Company Profile
STIM を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
STIM
Neuronetics Inc
|
2.75 | 175.23M | 69.23M | -33.10M | -39.26M | -1.18 |
|
ABT
Abbott Laboratories
|
123.11 | 214.96B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
98.93 | 149.24B | 19.35B | 2.78B | 3.49B | 1.8696 |
|
SYK
Stryker Corp
|
356.87 | 136.23B | 24.38B | 2.94B | 4.02B | 7.6145 |
|
MDT
Medtronic Plc
|
89.60 | 116.33B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
81.09 | 48.41B | 5.88B | 1.34B | 577.90M | 2.3455 |
Neuronetics Inc Stock (STIM) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-08-13 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2021-10-13 | ダウングレード | BTIG Research | Buy → Neutral |
| 2021-10-13 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2021-01-22 | アップグレード | William Blair | Mkt Perform → Outperform |
| 2020-02-06 | 開始されました | BTIG Research | Buy |
| 2018-07-24 | 開始されました | Canaccord Genuity | Buy |
すべてを表示
Neuronetics Inc (STIM) 最新ニュース
Neuronetics Inc (STIM) Q3 2025: Everything You Need To Know Ahea - GuruFocus
Neuronetics reports inducement grant - Medical Buyer
Is Neuronetics Inc. (NRC) stock a buy before earnings results2025 Geopolitical Influence & Growth Focused Entry Reports - newser.com
Why Neuronetics Inc. stock remains on watchlistsJuly 2025 Pullbacks & AI Forecasted Entry and Exit Points - newser.com
Real time alert setup for Neuronetics Inc. performanceMarket Risk Analysis & Expert-Curated Trade Recommendations - newser.com
Sentiment analysis tools applied to Neuronetics Inc.2025 Price Targets & Real-Time Price Movement Reports - newser.com
What does recent volatility data suggest for Neuronetics Inc.July 2025 Analyst Calls & Daily Technical Stock Forecast Reports - newser.com
Is Neuronetics Inc. stock attractive for long term wealth buildingWeekly Profit Analysis & Growth Focused Investment Plans - newser.com
Neuronetics Inc. stock trend forecast2025 Buyback Activity & Consistent Profit Alerts - newser.com
Will Neuronetics Inc. bounce back from current supportTrade Volume Report & Long-Term Safe Investment Ideas - newser.com
Will Neuronetics Inc. continue its uptrendWeekly Stock Summary & AI Forecast Swing Trade Picks - newser.com
Will Neuronetics Inc. stock maintain dividend yieldWeekly Gains Report & Verified Momentum Stock Alerts - newser.com
Analyzing net buyer seller activity in Neuronetics Inc.July 2025 Institutional & Verified Trade Idea Suggestions - newser.com
Is Neuronetics Inc. stock a top momentum playJuly 2025 Earnings & Trade Opportunity Analysis - newser.com
Detecting support and resistance levels for Neuronetics Inc.Profit Target & Low Risk Entry Point Guides - newser.com
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - The Globe and Mail
Neuronetics (NASDAQ: STIM) grants 38,850 RSUs to 12 employees under Nasdaq 5635(c)(4) - Stock Titan
Exit strategy if you’re trapped in Neuronetics Inc.2025 Trading Volume Trends & Comprehensive Market Scan Insights - newser.com
Can trapped investors hope for a rebound in Neuronetics Inc.Volume Spike & Risk Managed Trade Strategies - newser.com
Will Neuronetics Inc. stock maintain growth storyJuly 2025 Outlook & Fast Exit/Entry Strategy Plans - newser.com
Neuronetics signs exclusive TMS device agreement with Elite DNA - Investing.com
Neuronetics signs exclusive TMS device agreement with Elite DNA By Investing.com - Investing.com Canada
Neuronetics (STIM) Secures Exclusive Deal with Elite DNA Behavio - GuruFocus
Neuronetics Announces Three-Year Exclusive Partnership with Elite DNA Behavioral Health to Expand NeuroStar Access and Operational Excellence - The Manila Times
Neuronetics (NASDAQ: STIM) sole TMS provider to Elite DNA’s 30+ sites in 3‑year pact - Stock Titan
Neuronetics Revises Financial Results for Q4 and Full Year 2024 - MSN
Neuronetics (STIM) Expected to Announce Quarterly Earnings on Tuesday - MarketBeat
Is Neuronetics Inc. stock positioned well for digital economyJuly 2025 Decliners & Expert Verified Movement Alerts - fcp.pa.gov.br
Is the Valuation of Mauria Udyog Limited Sustainable P E and PEG BreakdownReal-Time Stock Alerts & Free High Yield Market Plays - earlytimes.in
Neuronetics Inc (STIM) 財務データ
収益
当期純利益
現金流量
EPS
1.38%
0.33%
大文字化:
|
ボリューム (24 時間):